The shareholders of both Guidant and Boston Scientific will benefit from the significant upside potential of the combined company, which will be strongly positioned in a wide range of medical markets and be supported by a more diversified base of revenues and earnings.
-Pete Nicholas
Select a background
More quotes by Pete Nicholas
Popular Authors
A curated listing of popular authors.